These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1250 related articles for article (PubMed ID: 21638053)
1. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells. Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053 [TBL] [Abstract][Full Text] [Related]
2. Activation of glucagon-like peptide-1 receptor inhibits growth and promotes apoptosis of human pancreatic cancer cells in a cAMP-dependent manner. Zhao H; Wei R; Wang L; Tian Q; Tao M; Ke J; Liu Y; Hou W; Zhang L; Yang J; Hong T Am J Physiol Endocrinol Metab; 2014 Jun; 306(12):E1431-41. PubMed ID: 24801389 [TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells. Koehler JA; Kain T; Drucker DJ Endocrinology; 2011 Sep; 152(9):3362-72. PubMed ID: 21771884 [TBL] [Abstract][Full Text] [Related]
4. Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor. Nuche-Berenguer B; Portal-Núñez S; Moreno P; González N; Acitores A; López-Herradón A; Esbrit P; Valverde I; Villanueva-Peñacarrillo ML J Cell Physiol; 2010 Nov; 225(2):585-92. PubMed ID: 20506394 [TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis. Marzioni M; Alpini G; Saccomanno S; Candelaresi C; Venter J; Rychlicki C; Fava G; Francis H; Trozzi L; Glaser S; Benedetti A Gastroenterology; 2007 Jul; 133(1):244-55. PubMed ID: 17631146 [TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice. Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472 [TBL] [Abstract][Full Text] [Related]
7. Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells. Li Y; Tweedie D; Mattson MP; Holloway HW; Greig NH J Neurochem; 2010 Jun; 113(6):1621-31. PubMed ID: 20374430 [TBL] [Abstract][Full Text] [Related]
8. Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: potential involvement of AKT and mitochondria biogenesis. Fan R; Li X; Gu X; Chan JC; Xu G Diabetes Obes Metab; 2010 Sep; 12(9):815-24. PubMed ID: 20649634 [TBL] [Abstract][Full Text] [Related]
9. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Granata R; Settanni F; Gallo D; Trovato L; Biancone L; Cantaluppi V; Nano R; Annunziata M; Campiglia P; Arnoletti E; Ghè C; Volante M; Papotti M; Muccioli G; Ghigo E Diabetes; 2008 Apr; 57(4):967-79. PubMed ID: 18162507 [TBL] [Abstract][Full Text] [Related]
11. Proximal cyclic AMP response element is essential for exendin-4 induction of rat EGR-1 gene. Kang JH; Kim MJ; Jang HI; Koh KH; Yum KS; Rhie DJ; Yoon SH; Hahn SJ; Kim MS; Jo YH Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E215-22. PubMed ID: 16926376 [TBL] [Abstract][Full Text] [Related]
12. Exendin-4 differentiation of a human pancreatic duct cell line into endocrine cells: involvement of PDX-1 and HNF3beta transcription factors. Zhou J; Pineyro MA; Wang X; Doyle ME; Egan JM J Cell Physiol; 2002 Sep; 192(3):304-14. PubMed ID: 12124776 [TBL] [Abstract][Full Text] [Related]
13. Exendin-4, a Glucagonlike Peptide-1 Receptor Agonist, Attenuates Breast Cancer Growth by Inhibiting NF-κB Activation. Iwaya C; Nomiyama T; Komatsu S; Kawanami T; Tsutsumi Y; Hamaguchi Y; Horikawa T; Yoshinaga Y; Yamashita S; Tanaka T; Terawaki Y; Tanabe M; Nabeshima K; Iwasaki A; Yanase T Endocrinology; 2017 Dec; 158(12):4218-4232. PubMed ID: 29045658 [TBL] [Abstract][Full Text] [Related]
14. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis. Baggio LL; Huang Q; Cao X; Drucker DJ Gastroenterology; 2008 Apr; 134(4):1137-47. PubMed ID: 18313669 [TBL] [Abstract][Full Text] [Related]
15. Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose. Burmeister MA; Ayala J; Drucker DJ; Ayala JE Am J Physiol Endocrinol Metab; 2013 Apr; 304(7):E677-85. PubMed ID: 23341495 [TBL] [Abstract][Full Text] [Related]
16. Exendin-4, a GLP-1 receptor agonist, attenuates prostate cancer growth. Nomiyama T; Kawanami T; Irie S; Hamaguchi Y; Terawaki Y; Murase K; Tsutsumi Y; Nagaishi R; Tanabe M; Morinaga H; Tanaka T; Mizoguchi M; Nabeshima K; Tanaka M; Yanase T Diabetes; 2014 Nov; 63(11):3891-905. PubMed ID: 24879833 [TBL] [Abstract][Full Text] [Related]
17. Increasing GLP-1-induced beta-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-alpha and DUSP14. Klinger S; Poussin C; Debril MB; Dolci W; Halban PA; Thorens B Diabetes; 2008 Mar; 57(3):584-93. PubMed ID: 18025410 [TBL] [Abstract][Full Text] [Related]